Respirology Search
Respirology Respirology
Most Read Articles
Antibiotic use may not be necessary in COPD patients with nonpurulent exacerbation
Stephen Padilla, 16 Oct 2019
Treatment without antibiotic medication does not appear to be inferior to moxifloxacin therapy as regards treatment failure or length of stay (LOS) among patients with chronic obstructive pulmonary disease (COPD) requiring hospitalization for nonpurulent exacerbation, according to the results of a study presented at the European Respiratory Society (ERS) International Congress 2019.
Prophylactic azithromycin may reduce exacerbations in primary antibody deficiencies
Roshini Claire Anthony, 16 Oct 2019

Antibiotic prophylaxis with azithromycin in individuals with primary antibody deficiencies (PAD) may lead to a reduced risk of respiratory exacerbations, according to a phase II trial presented at ERS 2019.
Unnecessary use of high-dose oral steroids prevalent in patients with severe asthma
Pearl Toh, 14 Oct 2019
About one-third of patients with severe asthma who are on high-dose inhaled corticosteroids (ICS) are also receiving excessive doses of oral corticosteroids (OCS), reveals a study presented at the ERS 2019 Meeting.
Immediate nicotine reduction best at cutting biomarkers of smoke exposure
Tristan Manalac, 11 Sep 2018
The immediate reduction of cigarette nicotine content results in greater improvements in levels of smoke exposure biomarkers than gradual reduction, though withdrawal symptoms are stronger, according to a recent study.

Podcast: Interview with Associate Prof Marysia Stella T. Recto: The role of bilastine in the treatment of allergic rhinitis and urticaria

01 Nov 2018
Podcast: Interview with Associate Prof Marysia Stella T. Recto: The role of bilastine in the treatment of allergic rhinitis  and urticaria
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Antibiotic use may not be necessary in COPD patients with nonpurulent exacerbation
Stephen Padilla, 16 Oct 2019
Treatment without antibiotic medication does not appear to be inferior to moxifloxacin therapy as regards treatment failure or length of stay (LOS) among patients with chronic obstructive pulmonary disease (COPD) requiring hospitalization for nonpurulent exacerbation, according to the results of a study presented at the European Respiratory Society (ERS) International Congress 2019.
Prophylactic azithromycin may reduce exacerbations in primary antibody deficiencies
Roshini Claire Anthony, 16 Oct 2019

Antibiotic prophylaxis with azithromycin in individuals with primary antibody deficiencies (PAD) may lead to a reduced risk of respiratory exacerbations, according to a phase II trial presented at ERS 2019.
Unnecessary use of high-dose oral steroids prevalent in patients with severe asthma
Pearl Toh, 14 Oct 2019
About one-third of patients with severe asthma who are on high-dose inhaled corticosteroids (ICS) are also receiving excessive doses of oral corticosteroids (OCS), reveals a study presented at the ERS 2019 Meeting.
Immediate nicotine reduction best at cutting biomarkers of smoke exposure
Tristan Manalac, 11 Sep 2018
The immediate reduction of cigarette nicotine content results in greater improvements in levels of smoke exposure biomarkers than gradual reduction, though withdrawal symptoms are stronger, according to a recent study.